Boston Scientific Statistics
Total Valuation
BSX has a market cap or net worth of $152.12 billion. The enterprise value is $162.83 billion.
Market Cap | 152.12B |
Enterprise Value | 162.83B |
Important Dates
The next estimated earnings date is Wednesday, July 23, 2025, before market open.
Earnings Date | Jul 23, 2025 |
Ex-Dividend Date | n/a |
Share Statistics
BSX has 1.48 billion shares outstanding. The number of shares has increased by 1.11% in one year.
Current Share Class | 1.48B |
Shares Outstanding | 1.48B |
Shares Change (YoY) | +1.11% |
Shares Change (QoQ) | +0.19% |
Owned by Insiders (%) | 0.18% |
Owned by Institutions (%) | 92.74% |
Float | 1.48B |
Valuation Ratios
The trailing PE ratio is 75.03 and the forward PE ratio is 34.88. BSX's PEG ratio is 2.84.
PE Ratio | 75.03 |
Forward PE | 34.88 |
PS Ratio | 8.60 |
Forward PS | 7.64 |
PB Ratio | 6.82 |
P/TBV Ratio | n/a |
P/FCF Ratio | 50.38 |
P/OCF Ratio | 39.83 |
PEG Ratio | 2.84 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 35.90, with an EV/FCF ratio of 54.03.
EV / Earnings | 80.13 |
EV / Sales | 9.28 |
EV / EBITDA | 35.90 |
EV / EBIT | 50.16 |
EV / FCF | 54.03 |
Financial Position
The company has a current ratio of 1.45, with a Debt / Equity ratio of 0.52.
Current Ratio | 1.45 |
Quick Ratio | 0.68 |
Debt / Equity | 0.52 |
Debt / EBITDA | 2.53 |
Debt / FCF | 3.88 |
Interest Coverage | 10.21 |
Financial Efficiency
Return on equity (ROE) is 9.50% and return on invested capital (ROIC) is 6.21%.
Return on Equity (ROE) | 9.50% |
Return on Assets (ROA) | 5.28% |
Return on Invested Capital (ROIC) | 6.21% |
Return on Capital Employed (ROCE) | 9.25% |
Revenue Per Employee | n/a |
Profits Per Employee | n/a |
Employee Count | n/a |
Asset Turnover | 0.46 |
Inventory Turnover | 2.04 |
Taxes
In the past 12 months, BSX has paid $454.00 million in taxes.
Income Tax | 454.00M |
Effective Tax Rate | 18.32% |
Stock Price Statistics
The stock price has increased by +35.93% in the last 52 weeks. The beta is 0.69, so BSX's price volatility has been lower than the market average.
Beta (5Y) | 0.69 |
52-Week Price Change | +35.93% |
50-Day Moving Average | 100.85 |
200-Day Moving Average | 93.85 |
Relative Strength Index (RSI) | 49.40 |
Average Volume (20 Days) | 6,767,843 |
Short Selling Information
The latest short interest is 16.75 million, so 1.13% of the outstanding shares have been sold short.
Short Interest | 16.75M |
Short Previous Month | 14.49M |
Short % of Shares Out | 1.13% |
Short % of Float | 1.14% |
Short Ratio (days to cover) | 2.40 |
Income Statement
In the last 12 months, BSX had revenue of $17.55 billion and earned $2.03 billion in profits. Earnings per share was $1.37.
Revenue | 17.55B |
Gross Profit | 12.02B |
Operating Income | 3.25B |
Pretax Income | n/a |
Net Income | 2.03B |
EBITDA | 4.54B |
EBIT | 3.25B |
Earnings Per Share (EPS) | $1.37 |
Balance Sheet
The company has $725.00 million in cash and $11.71 billion in debt, giving a net cash position of -$10.98 billion or -$7.42 per share.
Cash & Cash Equivalents | 725.00M |
Total Debt | 11.71B |
Net Cash | -10.98B |
Net Cash Per Share | -$7.42 |
Equity (Book Value) | 22.45B |
Book Value Per Share | 15.02 |
Working Capital | 2.28B |
Cash Flow
In the last 12 months, operating cash flow was $3.81 billion and capital expenditures -$798.00 million, giving a free cash flow of $3.01 billion.
Operating Cash Flow | 3.81B |
Capital Expenditures | -798.00M |
Free Cash Flow | 3.01B |
FCF Per Share | $2.04 |
Margins
Gross margin is 68.45%, with operating and profit margins of 18.49% and 11.58%.
Gross Margin | 68.45% |
Operating Margin | 18.49% |
Pretax Margin | 14.12% |
Profit Margin | 11.58% |
EBITDA Margin | 25.84% |
EBIT Margin | 18.49% |
FCF Margin | 17.17% |
Dividends & Yields
BSX does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -1.11% |
Shareholder Yield | -1.11% |
Earnings Yield | 1.34% |
FCF Yield | 1.98% |
Analyst Forecast
The average price target for BSX is $111.64, which is 8.57% higher than the current price. The consensus rating is "Strong Buy".
Price Target | $111.64 |
Price Target Difference | 8.57% |
Analyst Consensus | Strong Buy |
Analyst Count | 22 |
Revenue Growth Forecast (5Y) | 10.68% |
EPS Growth Forecast (5Y) | 29.25% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
Lynch Fair Value | |
Lynch Upside | |
Graham Number | |
Graham Upside |
Stock Splits
The last stock split was on November 6, 2003. It was a forward split with a ratio of 2:1.
Last Split Date | Nov 6, 2003 |
Split Type | Forward |
Split Ratio | 2:1 |
Scores
BSX has an Altman Z-Score of 5.13 and a Piotroski F-Score of 5.
Altman Z-Score | 5.13 |
Piotroski F-Score | 5 |